Marketing studies

Unit sales prices of from 800 to 900 fine chemicals are fisted weekly in the Chemical Marketing Reporter. This number reflects those fine chemicals produced and sold in industrial quantities. Some market studies on fine chemicals, fisting important product families, such as side chains for P-lactam antibiotics (qv). A/- and A-heterocycfic compounds, fluoroaromatics, etc, do exist (14,15). 

Telephone iaterviews are oftea substituted for persoaal visits or are used to supplemeat such visits. They do aot equal persoaal visits but are useful if only a few questions are iavolved or if time and cost parameters preclude extensive personal field calls. Time and cost factors have led to a decline ia the number of persoaal calls made by companies or coasultancys ia their market studies. 

Costs. There are two cost elements in doing marketing research studies professional charges and out-of-pocket expenses. The actual cost of any study is entirely dependent upon the number of interviews and the type of interviews. In practice, a 100-person interview study will cost 30,000 to 50,000. However, if a 50 x 10 investment is involved, the market study is cheap insurance. 

The market study conducted by Frost and Suiiivan [122] forecasted that sales of PBAs would continue strongly in the United States with consumption growing from the 1990s total of 363,000 MT to 466,000 MT in 1995. 

It must he produced in large quantities, over 100,000 per year and, being a domestic utility item, it should be priced low such as 3.00 at retail. Market studies indicate that it should be available in a wide range of colors. The size, quantity needed, and price suggest an IM in a TP material. A study of the cost and properties of the various plastics will show that in general the TPs will have the required properties at a lower cost than will the TSs. In addition they are more adaptable... 

PAMIR - A Market Study Giving First Insight... 

The diffusion of therapeutic innovations in the five markets studied depends more on the nationality of the inventor and the type of product than on therapeutic traditions. Each country tends to market its own innovations sooner and more extensively than those from abroad. 

PEI COPC (Prince Edward Island Certified Organic Producers Coop) (2005). COPC Undertakes Non GMO Markets Study, www.organicpei.com Accessed July 12, 2005. 

The last need translates into the requirement that plant sizes need to be consistent with the needs of utilities and other industries. To date, a detailed market study that clearly defines this need does not exist. Also, economy and efficiency means that plants that can be mass-produced and deployed on a modular basis must be developed. Finally, start-up and reliability problems can only be overcome by standardizing operations, which, as noted early on, will increase both investor and customer confidence. 

Phase IV. Studies or trials conducted after a medicine is marketed to provide additional details about the medicine s efficacy or safety profile. Different formulations, dosages, durations of treatment, medicine interactions, and other medicine comparisons may be evaluated. New age groups, races, and other types of patients can be studied. Detection and definition of previously unknown or inadequately quantified adverse reactions and related risk factors are an important aspect of many Phase IV studies. If a marketed medicine is to be evaluated for another (i.e., new) indication, then those clinical trials are considered Phase II clinical trials. The term postmarketing surveillance is frequently used to describe those clinical studies in Phase IV (i.e., the period following marketing) that are primarily observational or nonexperimental in nature, to distinguish them from well-controlled Phase IV clinical trials or marketing studies. 

Post-marketing studies of cohorts of patients, often assembled by practitioners with the support of the relevant pharmaceutical company, may also be useful in detecting ADRs related to new drugs but they have been criticised for their small size and that they are interventional. These criticisms are supported by the history of some of these studies, but they cannot be seen as intrinsic reasons why the approach is not valid if the studies are carried out properly and to completion. 

A recently published and interesting market study by Yole Developpement estimates the high-frequency market for SiG MESFETs to be 400 million in 2007 [65]. This also takes into account a dramatic annual price reduction of the components. 

The market study by Yole estimates the SiC power-device market to be close to 600 million in 2007 and growing rapidly. This also covers bipolar devices, which are at higher voltages. 

Yole Developpement, Evaluation of the 2002-2007 SiC Market and Analysis of the Maj or Technology and Industrials Trend, market study, 2003. 

This is what puts life into what otherwise may be merely a sterile collection of data—it puts the ting into marketing research. Now let s see how this pertains specifically to the field of engineering plastics. Let s suppose we are starting out on a hypothetical marketing study. 

---